INSPECS Group plc Stock
Stocks
SPEC
GB00BK6JPP03
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
London S.E.
11:35:01 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 90.00 GBX | 0.00% |
|
0.00% | +25.87% |
| 09-10 | EARNINGS AND TRADING: Physiomics celebrates new contract wins | AN |
| 09-10 | INSPECS Group plc Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 131M 117M 108M 98.36M 185M 12.45B 188M 1.3B 511M 6.49B 492M 481M 20.7B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 87M 77.57M 71.72M 65.28M 123M 8.26B 125M 861M 339M 4.31B 326M 320M 13.74B | EV / Sales 2026 * |
0.33x | EV / Sales 2027 * | 0.31x |
| Free-Float |
10.75% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| SPEC | Delayed | |
Deutsche Boerse AG
| 4GV | Delayed |
| 03-04 | Form 8.3 - Inspecs Group Plc | AQ |
| 02-11 | Form 8.3 - Inspecs Group Plc | AQ |
| 02-09 | Form 8.3 - [INSPECS GROUP PLC - 06 02 2026] - (CGAML) | AQ |
| 01-27 | Form 8.3 - Inspecs Group Plc | AQ |
| 01-07 | Form 8.3 - Inspecs Group Plc | AQ |
| Current month | -3.74% | ||
| 1 month | -6.25% | ||
| 3 months | -7.22% | ||
| 6 months | +7.78% | ||
| Current year | +25.87% |
| 1 week | 87 |  | 93 |
| 1 month | 87 | | 100 |
| Current year | 60 | | 105 |
| 1 year | 40 | | 105 |
| 3 years | 37 | | 105 |
| 5 years | 37 | | 420 |
| 10 years | 37 | | 420 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Peck
CEO | Chief Executive Officer | 62 | 2022-11-30 |
Christopher Kay
DFI | Director of Finance/CFO | 63 | - |
Angela Eman
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Peck
BRD | Director/Board Member | 62 | 2020-01-09 |
Angela Farrugia
BRD | Director/Board Member | 61 | 2020-05-11 |
Luke Johnson
BRD | Director/Board Member | 64 | 2026-05-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/4/25 | Free | Chief Executive Officer | 250,000 | 0.2459% | ||
| 6/4/25 | Free | Chief Executive Officer | 150,000 | 0.1475% | ||
| 11/8/22 | Buy | Chief Executive Officer | 833,333 | 0.8196% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +104.55% | +9.09% | 131M | |
| +0.20% | +5.31% | -18.40% | +13.84% | 181B | |
| -0.73% | +7.09% | -1.08% | +30.13% | 116B | |
| +0.49% | +6.25% | -21.30% | +9.62% | 113B | |
| +3.83% | +5.50% | -50.59% | -6.11% | 79.83B | |
| -0.14% | +5.27% | +5.00% | +81.87% | 65.06B | |
| +2.79% | +2.37% | +15.85% | +65.97% | 54.35B | |
| -1.04% | +4.35% | +1.40% | -26.05% | 52.23B | |
| +2.41% | +8.18% | -11.81% | +28.50% | 44.15B | |
| -1.90% | +2.29% | +29.19% | +6.90% | 32.47B | |
| Average | +0.59% | +4.76% | +5.28% | +21.38% | 73.87B | |
| Weighted average by Cap. | +0.60% | +5.59% | -11.11% | +21.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 267M 238M 220M 200M 377M 25.37B 384M 2.64B 1.04B 13.23B 1B 981M 42.19B | 277M 247M 228M 208M 391M 26.27B 397M 2.74B 1.08B 13.7B 1.04B 1.02B 43.69B |
| Net income | - | - |
| Net Debt | -44.08M -39.29M -36.33M -33.07M -62.26M -4.19B -63.3M -436M -172M -2.18B -165M -162M -6.96B | -45.44M -40.51M -37.46M -34.1M -64.18M -4.31B -65.26M -450M -177M -2.25B -171M -167M -7.18B |
Employees
1,656
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | GBX 90.00 | 0.00% | 0 |
| 26-10-15 | GBX 90.00 | 0.00% | 22 |
| 26-10-14 | GBX 90.00 | 0.00% | 62 |
| 26-10-13 | GBX 90.00 | 0.00% | 0 |
| 26-10-12 | GBX 90.00 | 0.00% | 3,506 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.201USD
Average target price
0.8180USD
Spread / Average Target
-31.87%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SPEC Stock
Select your edition
All financial news and data tailored to specific country editions
